ESTRO GUIDE 2017

PHYSICS PRE-MEETING COURSE Medical physics aspects of particle therapy

FRIDAY 5 MAY 2017 Course directors: M. Schwarz (IT) and J. Farr (USA)

COURSE AIM The use of “heavy” charged particles (mostly protons and carbon ions) is an expanding modality in radia- tion oncology and such expansion is in advance of the number of trained medical physicists in the field. In addition, patients who may benefit from particle ther- apy are often referred from X-ray treatment facilities. To assist in external referrals, all therapeutic medical physicists should have some knowledge of particle ther- apy, and this course seeks to provide this introductory education. Due to the evolutionary nature of particle therapy, a balance of fundamental and current topics will be covered. LEARNINGOBJECTIVES Upon completion of the course, successful learners will be able to: • Comprehend basic particle interactions with matter and radiobiology • Compare aspects of particle therapy systems • Know methods of particle beam dosimetry • Discover insight into particle therapy specific imaging • Know about acceptance testing and clinical commissioning • Comprehend machine and patient specific quality assurance methods • Critique particle therapy specific treatment planning techniques • Compare particle therapy with photon therapy treat- ment plans • Interpret particle therapy uncertainties, detections, and their mitigations • Appraise how to select the most appropriate patient indications for particle therapy. WHO SHOULD ATTEND? The target group consists of medical physicists, medical physics assistants, dosimetrists and researchers who are interested in improving their knowledge of clinical particle therapy.

CONTENT • Clinical perspective of particle beam therapy • Particle beam interactions • Radiobiology of particle beam • Particle therapy systems • Particle specific imaging • Particle therapy detectors and sensors • Acceptance testing of particle therapy systems • Clinical commissioning of particle therapy systems • Uncertainties and their dosimetric impact

• Treatment planning • Motion management

• In-vivo dosimetry for patient dose verification • Outlook and future directions of particle therapy.

132

ESTRO CONFERENCES